Richboro, PA, United States of America

Thomas A Wheatley



Average Co-Inventor Count = 1.7

ph-index = 8

Forward Citations = 340(Granted Patents)


Location History:

  • Houston, TX (US) (1976 - 1982)
  • Richboro, PA (US) (1987 - 1998)

Company Filing History:


Years Active: 1976-1998

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Inventive Mind of Thomas A Wheatley

Introduction:

Thomas A Wheatley, a talented inventor hailing from Richboro, PA, has made significant contributions to the field of pharmaceutical technology with a total of six patented inventions under his belt.

Latest Patents:

Among his latest patents is the 'Microcrystalline Cellulose Spheronization Composition,' a groundbreaking particulate co-processed microcrystalline cellulose and hydrocolloid blend ideal for spheronizing agents in drug production. He also developed a 'Readily Available Konjac Glucomannan as a Sustained Release Excipient' for pharmaceutical tablets, showcasing his innovative approach to drug delivery systems.

Career Highlights:

Thomas A Wheatley has been instrumental in driving innovation at FMC Corporation, a renowned organization in the pharmaceutical industry. His expertise in developing novel compositions for drug manufacturing has earned him recognition as a pioneer in the field.

Collaborations:

Collaborating with esteemed colleagues Clayton I Bridges, Jr. and Carl R Steuernagel, Thomas A Wheatley has synergized efforts to bring forth cutting-edge solutions in pharmaceutical technology. Their combined expertise has led to the development of groundbreaking inventions that have the potential to revolutionize the industry.

Conclusion:

In conclusion, Thomas A Wheatley's inventive spirit and dedication to advancing pharmaceutical technology have cemented his position as a prominent figure in the realm of innovation. His patents not only reflect his ingenuity but also demonstrate his commitment to transforming the landscape of drug manufacturing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…